Arkolith/Insider Trading/IMPL/Form 4

Kravis Henry R

10% OwnerIMPEL NEUROPHARMA INC (IMPL) · full profile →Form 4 · filed Apr 29, 2021
Net Buying
Open-Market Buys
$16.5M
Open-Market Sells
$0
Net Open-Market Flow
$16.5M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2021Other(J)119K$13.50$1.6M2.7M
Apr 27, 2021Conversion(C)2.6M——2.6M
Apr 27, 2021Buy(P)1.1M$15.00$16.5M3.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2021Conversion(C)42.3M——0

Transaction Codes

J
Other acquisition / disposition
C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-21-014994) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML